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Mice deficient for the Abdominal B (AbdB) Hox gene Hoxa-10 exhibit reduced fertility due to defects in implantation.
During the peri-implantation period Hoxa-10 is sequentially expressed in the uterine epithelium and stroma. These
observations, combined with the stringent regulation of uterine implantation by ovarian steroids, prompted us to test
whether estrogen and progesterone directly regulate the expression of Hoxa-10 and other AbdB Hoxa genes. Here we show
that Hoxa-10 expression in the adult uterus is strongly activated by progesterone. This activation is blocked by the
progesterone receptor antagonist RU486 and is independent of new protein synthesis. In addition, Hoxa-10 expression is
repressed by estrogen in a protein synthesis-independent manner. Analysis of adjacent AbdB Hoxa genes reveals that
Hoxa-9 and a-11 are also activated in a colinear fashion by progesterone but differentially regulated by estrogen. These
results suggest that the regulation of AbdB Hox gene expression in the adult uterus by ovarian steroids is a property related
to position within the cluster, mediated by the direct action of estrogen and progesterone receptors upon these genes. We
next examined whether the embryonic expression of Hoxa10 is regulable by hormonal factors. Previous work has
demonstrated that perinatal administration of the synthetic estrogen diethylstilbestrol (DES) to mice and humans produces
uterine, cervical, and oviductal malformations. Certain of these phenotypes resemble those in Hoxa-10 knockout mice,
suggesting that Hoxa-10 gene expression might be repressed by DES during reproductive tract morphogenesis. Exposure of
the developing female reproductive tract to DES, either in vivo or in organ culture, represses the expression of Hoxa-10 in
the Mu¨llerian duct. Thus, these data not only establish a direct link between ovarian steroids and AbdB Hoxa gene
expression in the adult uterus, but also provide a potential mechanism for the teratogenic effects of DES on the developing
reproductive tract. © 1998 Academic Press
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INTRODUCTION
The development of the male and female reproductive
tracts requires the respective regional specification of the
Wolffian and Mu¨llerian ducts. Gonadal hormones are re-
sponsible for the further differentiation of both ducts. In
males, androgens promote the development of the Wolffian
ducts into the epididymis and vas deferens while in females
the absence of testes-derived Mu¨llerian inhibitory sub-
stance (MIS) permits Mu¨llerian duct differentiation into the
oviduct, uterus, and upper vagina (reviewed in Cunha, 1976;
Sadler, 1990). One determinant of segmental identity along
the proximodistal axis of these ducts are members of the
Abdominal B (AbdB) Hox gene family which, in the case of
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the Hoxd cluster, exhibit nested, overlapping boundaries of
expression, thus comprising a Hox code within the devel-
oping reproductive tract (Dolle´ et al., 1991). Moreover,
knockout of the AbdB genes Hoxa-10, a-11, a-13, and d-13
supports this view. Each of these mutations produces re-
stricted morphologic defects that correlate with anterior
expression boundaries along the proximodistal axis of these
ducts. In some cases, these defects can be interpreted as
homeotic transformations (Benson et al., 1996; Hsieh-Li et
al., 1995; Podlasek et al., 1997). Thus, a sequential cascade
of hormonal and homeotic regulatory factors appears to
control morphogenesis of the reproductive tract.
During adult life, the functioning of the female reproduc-
tive tract is also under the control of hormonal and Hox
gene regulation. In early pregnancy, the establishment of a
suitable uterine environment is crucial for successful im-
plantation and the window for implantation is narrow,
under strict regulation by ovarian hormones. The epithe-
lium becomes a suitable surface for embryo attachment and
the stromal fibroblasts become competent to undergo trans-
formation into specialized decidual cells. The action of
progesterone in priming the uterus is absolutely essential to
confer uterine receptivity. In the absence of progesterone,
the embryo remains in a state of diapause, and only after
endometrial preparation by progesterone has been com-
pleted is estrogen effective in inducing a state of receptivity
(reviewed in Psychoyos, 1973). The nidatory secretion of
estrogen, acting upon the progesterone-primed uterus, is
also essential, since eliminating it by ovariectomy or lacta-
tion prevents the attachment reaction and the blastocyst
remains in a delayed implantation state (McLaren, 1968).
While the molecular mechanism for uterine receptivity
remains largely unknown, targeted mutagenesis in mouse
has provided some clues to the maternal regulators of this
process. We recently characterized the mechanism for re-
duced fertility in Hoxa-10 mutant mice and identified a role
for Hoxa-10 in mediating vascular permeability and stromal
decidualization during early implantation (Benson et al.,
1996). Thus, reproductive function is highly regulated by
both steroid hormones and Hox genes.
Retinoic acid (RA), acting through distinct members of
the nuclear receptor superfamily, appears to be one regula-
tor of Hox gene expression (reviewed in Conlon, 1995;
Means and Gudas, 1995; Marshall, 1996). Exogenous reti-
noic acid alters the expression domains of the Antp-class
Hox genes situated at the 39 ends of the Hox clusters and
results in transformations of segmental identity of anterior
rhombomeres and vertebral segments (Conlon and Rossant,
1992; Marshall et al., 1992; Kessel, 1992; Morriss-Kay et al.,
1994; Wood et al., 1994). In cultured cells, the responsive-
ness of Hox genes to RA is colinear with their position
within the cluster: 39 Hox genes are the most sensitive,
being activated first and to the highest levels, with a
progressive decrease in sensitivity proceeding 59 across the
cluster (Boncinelli et al., 1991; Stornaiuolo et al., 1990). In
contrast, the expression of 59 AbdB Hox genes is repressed
by administration of RA to cultured cells or mouse embryos
(Simeone et al., 1991; Kessell, 1992). Potential retinoic acid
response elements (RAREs) have been identified in the
promoters of several Hox genes including Hoxa-1 (Langston
and Gudas, 1992; Frasch et al., 1995), Hoxb-1 (Marshall et
al., 1994; Studer et al., 1994), and Hoxd-4 (Po¨pperl and
Featherstone, 1993; Morrison et al., 1996), and recently one
RARE was shown to be necessary for establishing the
Hoxa-1 anterior expression boundary in the neural plate
(Dupe´ et al., 1997). Thus, retinoids appear to provide one
mechanism for the endogenous regulation of Hox gene
expression.
In this paper, we demonstrate that in adult mouse uterus,
Hoxa-9, -10, and -11 expression is under the control of both
estrogen and progesterone. The hormonal regulation of
AbdB Hoxa genes by ovarian steroids affords insight into
how members of the Hox and hormone nuclear receptor
families may be functionally related during embryo implan-
tation. In addition, in the developing reproductive tract,
AbdB Hoxa genes are expressed in a nested pattern along
the anteroposterior axis of the Mu¨llerian duct, consistent
with the existence of a Hox code governing development of
these structures. Expression of one of these genes, Hoxa10,
is potently repressed by in vivo administration of the
synthetic estrogen diethylstilbestrol (DES). Since DES pro-
duces malformations of both male and female reproductive
tracts comparable to those observed in AbdB Hox knockout
mice, these results provide a potential molecular explana-
tion for some of the teratogenic effects of DES upon the
developing reproductive tract.
MATERIALS AND METHODS
Steroid treatments. Ovariectomized IRS female mice (Taconic)
received 17b-estradiol (E2) and progesterone (P4) alone or in com-
bination according to either of two protocols. In the first protocol,
mice received E2 (250 ng/mouse) or P4 (1 mg/mouse) alone or in
combination. Steroids were dissolved in sesame oil and injected sc
(0.1 ml/mouse). Control animals received oil only. Mice were
sacrificed at 2, 4, 6, 8, 16, and 24 h following injection and uteri
were collected for RNA extraction or fixed in 4% paraformaldehyde
for in situ hybridization. To assess whether steroidal effects were
direct, mice were injected ip with cycloheximide (100 mg/mouse)
30 min prior to steroid treatment (Gorski and Axman, 1964). Mice
pretreated with cycloheximide were sacrificed 4 h post-steroid
treatment administered as described above. In the second protocol,
ovariectomized mice received P4 (2 mg/mouse) for 2 consecutive
days with or without E2 (100 ng/mouse) on day 2, followed by
expression analysis after 24 h. This regimen has previously been
shown to support blastocyst implantation (Das et al., 1995). For
experiments involving RU486 (a gift from Roussel-Uclaf, Romain-
ville, France), mice were injected sc with 400 mg RU486 with each
P4 injection using the protocol of steroid administration just
described; control mice received vehicle alone (0.1 ml oil/mouse).
In situ hybridization. Radioactive and whole-mount in situ
hybridizations were performed as previously described on adult
uterine sections or intact E15.5–P5 reproductive tracts, respec-
tively (Benson et al., 1996). The same probes were employed for
radioactive and whole-mount in situ hybridizations and for RNAse
protection except for Hoxa-13 (see below). The Hoxa-10 RNA
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probe was transcribed from a pGEM3Z plasmid encoding transcript
a10-2, linearized with XhoI (Benson et al., 1995). Transcription
with SP6 polymerase resulted in a 316-bp RNA probe (nt 1110–
1426) which detects all three Hoxa-10 transcripts (Benson et al.,
1995). RNA probes were prepared for Hoxa-9 from an AvaII
restricted plasmid 23.5 using T7 polymerase (nt 267–493; Rubin et
al., 1987), for Hoxa-11 from an AgeI restricted plasmid 23.8 using
T7 polymerase (nt 7033–7270; Hsieh-Li et al., 1995), and for
Hoxa-13 from a SpeI restricted plasmid 23.1 (consisting mainly of
39 UTR) using T7 polymerase. An antisense RNA probe for c-myc
was made as previously described (Morgenbesser et al., 1995). An
antisense RNA probe for the mouse RPL19 gene (Nakamura et al.,
1990) was synthesized from a PCR fragment (nt 4–567) cloned into
pCR2.1 (InVitrogen), linearized with NdeI, and transcribed with T7
polymerase. In all cases, sense RNA probes did not demonstrate
any specific hybridization signals.
RNase protection assays. [32P]UTP antisense RNA probes were
prepared as described above. An antisense probe for Hoxa-13 was
prepared from a XbaI restricted plasmid 23.1 using T7 polymerase.
Analyses were performed as described (Krieg and Melton, 1987). For
each lane, 20 mg total RNA was hybridized for 16 h at 45°C simulta-
neously with 3 3 105 cpm of RNA probes for each of Hoxa-9, -10, -11,
and -13 and with 2 3 104 cpm of RPL19 RNA probe and then digested
with 20 mg/ml RNAse A and 1.5 mg/ml RNAse T1. Protected
fragments were electrophoresed in a 6% denaturing polyacrylamide
gel and analyzed by autoradiography. Sizes for protected fragments are
226 bp for Hoxa-9, 316 bp for Hoxa-10, 237 bp for Hoxa-11, 530 bp for
Hoxa-13, and 215 bp for RPL19.
Northern blot analyses. Poly(A)1 RNA samples were isolated
by oligo(dT)–cellulose column chromatography (Sambrook et al.,
1989). Poly(A)1 RNA samples (2 mg) were denatured, separated by
formaldehyde–agarose gel electrophoresis, transferred, and cross-
linked to nylon membranes by UV irradiation. Northern blots were
prehybridized and hybridized as described previously (Das et al.,
1995) with the antisense 32P-labeled RNA probes described above
or with an RPL7 probe for normalization (Lim et al., 1997). Filters
were stripped of hybridized probe and reprobed as described previ-
ously (Das et al., 1995).
DES treatments in vivo and in organ culture. Two different in
vivo regimens were used to assess the results of DES (Sigma No.
D4628) on Hoxa10 gene expression. Both regimens have been
previously shown to produce reproductive tract malformations in a
variety of inbred mouse strains (Newbold and McLachlan, 1982). In
the prenatal regimen, pregnant ICR (Taconic) females were injected
sc with a dose of 100 mg/kg/day of DES (;3 mg/pregnant female)
from 9.5 to 16.5 pc and sacrificed 6 h after the E16.5 injection. In a
second neonatal regimen employing higher doses of DES, either
ICR or Swiss Webster (Taconic) neonates (;2 g each) were injected
sc with a dose of 1 mg/kg/day (;2 mg/newborn) from P1 to P5 and
sacrificed 6 h after the P5 injection. DES efficacy was verified in
ICR neonates by increased thickening of the luminal epithelium
(Fig. 7D). Finally, in some experiments, pregnant mice received a
single fetotoxic dose of DES (500 mg) on E16.5 with sacrifice on
E17.5. For the prenatal regimen, DES was dissolved in ethanol at 3
mg/ml, diluted 100-fold in sesame oil, and injected in a volume of
100 ml. For the neonatal regimen, DES was dissolved in ethanol at
10 mg/ml, diluted 100-fold in corn oil, and injected in a volume of
20 ml. Reproductive tracts were harvested, fixed, and subjected to
whole-mount in situ hybridization for AbdB Hoxa or RPL19
(control) expression.
For organ culture experiments, male or female reproductive
tracts from E15.5 through P1 were dissected and cultured in
24-well dishes in 2 ml DMEM plus 10% fetal calf serum and
penicillin–streptomycin for 5 h (37°C, 5% CO2) with or without
1024 to 1026 M DES. Control experiments were performed under
similar conditions with testosterone and dexamethasone. Tissues
were washed twice in PBS before fixation in 4% paraformaldehyde
overnight and whole-mount in situ analysis.
RESULTS
Hoxa-10 is regulated by steroids in the uterine stroma.
To examine the steroidal control of Hoxa-10 in the uterus,
ovariectomized females were injected sc with 250 ng 17b-
estradiol (E2), 1 mg progesterone (P4), or a combination of
both. The injection of oil vehicle alone served as a control.
The expression of Hoxa-10 in the uteri was examined at 2,
4, 8, and 16 h following injection. Hoxa-10 is expressed at a
basal level in the subepithelial stroma and circular muscle
layer of the myometrium in all oil-injected controls (Figs.
1A, 1E, and 1I). While Hoxa-10 expression is present in the
subepithelial stroma and circular muscle at 2 h following
E2 exposure (Fig. 1B), expression is sharply reduced in the
stroma by 4 h (Fig. 1F). This result is consistent with the
early postovulatory phase of endogenous estrogen exposure
on day 0.5 pc when the uterine stroma is devoid of Hoxa-10
expression (Satokata et al., 1995). Expression of Hoxa-10 is
still detected in the circular muscle layer at this time.
Stromal expression remains low at 8 h (Fig. 1J), but by 16 h
post-E2 treatment Hoxa-10 is expressed diffusely through-
out the stroma (data not shown). Hoxa-10 is normally
expressed in the uterine epithelium on day 0.5 pc following
the release of the ovulatory pulse of estrogen; however,
epithelial expression was not induced in the E2-treated
uteri at any time point examined and was also not activated
by steroid combinations (see below). The epithelium was
intact as judged by Hoescht dye nuclear fluorescence and
detection of c-myc expression.
In contrast to the effects of E2, Hoxa-10 expression is
strongly upregulated in both the stroma and circular muscle
following exposure to progesterone (P4) (Figs. 1C, 1G, and
1K). Induction, first weakly observable at 2 h, continues to
increase, reaching a peak at 8 h. Although the initial
induction is concentrated in the subepithelial stroma (Figs.
1C and 1G), Hoxa-10 expression expands to the deeper
layers of the stroma. By 8 h the expression in the stroma
extends to the border of the circular muscle so that the
expression domains are contiguous (Fig. 1K). At 16 h,
hybridization above the oil control is still observed, but is
decreased in intensity compared to 8 h (data not shown).
When estradiol and progesterone were given in combina-
tion (E2 1 P4), a unique response was observed (Figs. 1D,
1H, and 1L). At 2 h posttreatment, the expression pattern
resembled that of P4 alone, although the stromal expression
was limited to a somewhat narrower zone (Fig. 1D). Sur-
prisingly, at 4 h following injection, Hoxa-10 expression
became restricted to the antimesometrial pole of the uterus
where it is expressed in a thin layer of stroma immediately
below the epithelium (Fig. 1H, arrow, inset). This asymmet-
ric expression was consistently observed on multiple sec-
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tions in five separate 4-h, E2 1 P4-treated uteri. A weak
antimesometrial bias could be observed in the basal expres-
sion in oil controls but was not refined to this extent. The
induction of expression by P4 alone was always equivalent
in the mesometrial and antimesometrial regions. At 8 h
posttreatment, this regionalization had disappeared and
Hoxa-10 expression appeared weak and diffuse throughout
the stroma (Fig. 1L). Finally, at 16 h, expression increased in
the stroma and circular muscle, suggesting a second phase
of upregulation (data not shown).
RNase protection analyses were used to further corrobo-
rate and quantitate the regulation of Hoxa-10. Ovariecto-
mized mice were injected with steroids at the same dose as
in the in situ experiments and RNA was prepared from total
uteri. A representative RNase protection experiment is
shown using RNA from 4 and 8 h post-steroid treatment
(Fig. 2A) with RPL19 (encoding ribosomal protein L19) as a
loading control. Quantification of six separate 4-h experi-
ments is shown in Fig. 2B. No differences in Hoxa-10
uterine expression were observed between uninjected mice
FIG. 1. Steroidal regulation of Hoxa-10. Adult ovariectomized female mice were injected with oil (A, E, I), 250 ng 17b-estradiol (E2) (B,
F, J), 1 mg progesterone (P4) (C, G, K), or 250 ng 17b-estradiol and 1 mg progesterone (E2 1 P4) (D, H, L) and sacrificed at 2 h (A–D), 4 h (E–H),
and 8 h (I–L). In situ hybridization was performed with a Hoxa-10 RNA probe. Hoxa-10 is expressed at a basal level in the stroma and
circular muscle layer of oil-injected controls. Stromal expression is inhibited by E2 and activated by P4 in these cell types. Combined E2 1
P4 restricts expression to subepithelial stromal cells of the antimesometrial pole (arrow, H, and inset). The open lumen in L is likely to be
an artifact of paraformaldehyde fixation. By convention, all uteri are shown oriented with the antimesometrial pole at the bottom. Sense
control RNA probes showed no specific hybridization signals. Abbreviations: cm, circular muscle; e, uterine epithelium; s, uterine stroma.
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and vehicle-injected controls. E2 represses Hoxa-10 expres-
sion approximately 0.5 6 0.02-fold (n˜ 6 SEM) compared to
oil-injected mice, whereas P4 activates Hoxa-10 expression
by an average of 2.4 6 0.1-fold. Because these experiments
used total uterine RNA, stromal RNA is diluted with that
of steroid nonresponsive uterine tissues; hence, these val-
ues probably underestimate the changes in stromal expres-
sion. E2 1 P4 treatment produces Hoxa-10 expression
levels comparable to those of the controls (Figs. 2A and 2B).
By 8 h, repression by E2 starts to diminish, whereas P4
activation peaks at 2.7-fold (Fig. 2A, lanes 8 and 9). Coad-
ministration of E2 1 P4 reduces Hoxa-10 expression to
control levels (Fig. 2A, lane 10). Similar results were ob-
tained by Northern blot analyses (see below).
Steroid hormone regulation of Hoxa-10 expression oc-
curs under physiologic conditions and is blocked by the
progesterone receptor antagonist RU486. To test whether
the hormonal regulation of Hoxa-10 could be obtained
under a physiologic regimen of steroid administration ca-
pable of supporting implantation (Das et al., 1995), ovari-
ectomized mice were treated with P4 (2 mg) on 2 consecu-
tive days with or without E2 (100 ng) on day 2, followed by
assay of Hoxa-10 expression 24 h later. Both conditions
strongly induced Hoxa-10 expression in the uterine stroma
(Figs. 3A and 3B), whereas vehicle-injected controls exhib-
ited only weak basal expression similar to Fig. 3D (data not
shown). To test whether the induction of Hoxa-10 expres-
sion by progesterone is mediated through the progesterone
receptor (PR), we coadministered RU486, a known proges-
terone antagonist that binds the PR and inactivates PR-
FIG. 2. Quantitation of the steroidal regulation of Hoxa-10 by
RNase protection assay. Ovariectomized mice were injected with or
without vehicle alone (oil), 250 ng 17b-estradiol (E2), 1 mg progester-
one (P4), or the combination of estrogen and progesterone (E2 1 P4).
Uteri were harvested either 4 or 8 h after the injection and total RNAs
were extracted. (A) RNase protection assays were performed by
hybridizing 20 mg of total RNA with antisense RNA probes for
Hoxa-10 and RPL19. Compared to uninjected or oil-injected (lanes 1,
2, 6, and 7) mice, E2 significantly represses Hoxa-10 expression in the
uterus after 4 h (lane 3), whereas P4 activates Hoxa-10 expression
(lane 4). By 8 h, repression of Hoxa10 expression by E2 starts to
diminish (lane 8), whereas activation by P4 peaks (lane 9). Injection of
E2 1 P4 negates the activation by P4 alone (lanes 5 and 10). Lane 11
shows yeast tRNA as a negative control. (B) Six sets of experiments
after 4 h of hormone treatment were performed and the results
quantitated using a phosphorimager. Results shown are average fold
inductions 6 SEM. Intensity of the Hoxa-10 bands was normalized
against RPL19 as a loading control.
FIG. 3. The progesterone antagonist RU486 blocks the proges-
terone (P4)-dependent activation of Hoxa-10. Ovariectomized
mice were injected with 2 mg P4 on 2 consecutive days without
(A) or with (B) 100 ng 17b-estradiol (E2) on day 2 as indicated.
Twenty-four hours after the last injection, uteri were harvested
and sectioned longitudinally and in situ hybridization was per-
formed using an 35S-labeled Hoxa-10 antisense RNA probe. Both
regimens strongly activate Hoxa-10 stromal expression (A and B)
compared to oil vehicle-injected controls which resembled D
(not shown). To assess the effects of RU486, 400 mg RU486 was
injected with P4 according to the above regimen. RU486 partly
blocks the activation of Hoxa-10 expression by P4 alone (C),
while complete inhibition occurs when RU486 is coadminis-
tered with P4 1 E2 (D). Abbreviations: le, luminal epithelium;
myo, myometrium; s, stroma.
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dependent transcriptional activation (reviewed in Spitz and
Bardin, 1993). RU486 markedly reduced the P4-dependent
activation of Hoxa-10 stromal expression (Fig. 3C) and
when coadministered with E2 and P4 further reduced
Hoxa-10 expression to basal levels (Fig. 3D). These results
support the conclusion that the progesterone receptor is
involved in positively regulating Hoxa-10 expression in
uterine stroma.
Steroidal regulation of Hoxa-10 expression is cyclohex-
imide resistant. To determine whether steroidal regula-
tion of uterine Hoxa-10 expression is dependent on new
protein synthesis, ovariectomized females were injected
with 100 mg of cycloheximide 30 min prior to steroid
treatment. This cycloheximide dose reduces glycine-2-C14
incorporation by 90% in the immature rat uterus for up to
a 6-h period (Gorski and Axman, 1964). Because of concerns
about possible cycloheximide toxicity, a 4-h time point was
assayed. As a control for the efficacy of the dose, the
expression of c-myc was examined in steroid-treated uteri
with and without cycloheximide. In the absence of cyclo-
heximide, c-myc is detected in the epithelium of E2-treated
uteri and in the stroma of P4- and E2 1 P4-treated uteri
FIG. 4. Resistance of steroid-induction of Hoxa-10 to cycloheximide. Comparison of c-myc (A–H) and Hoxa-10 expression (I–L) in
ovariectomized females 4 h following steroid administration, in the absence (A–D) and presence (E–L) of pretreatment with 100 mg
cycloheximide 30 min prior to steroid injection. The epithelial expression of c-myc in E2 uteri is inhibited by cycloheximide (see insets in
B and F) while the stromal expression in P4 uteri is slightly increased. Hoxa-10 expression shows no change in steroid induction with
cycloheximide treatment (compare Figs. 1E–1H). As in Fig. 1, E2 1 P4 results in restriction of Hoxa-10 expression to the subepithelial
stroma at the antimesometrial pole (L, arrow).
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(Figs. 4A–4D), as shown previously (Huet-Hudson et al.,
1989). However, pretreatment with cycloheximide pre-
vented the E2-induced upregulation of c-myc in the epithe-
lium (Fig. 4F, inset) and slightly increased the P4- and E2 1
P4-mediated response (Figs. 4G and 4H). In contrast, cyclo-
heximide treatment did not alter either the repression of
Hoxa-10 by E2 or its activation by P4 (compare Figs. 4I–4L
to Figs. 1E–1H). Notably, the restriction of expression to the
antimesometrial pole following combined E2 1 P4 treat-
ment was also unaffected (Fig. 4L, arrow). These results
suggest that Hoxa-10 is a direct target of regulation by the
estrogen and progesterone receptors.
Regulation of other AbdB Hoxa genes in the uterus by
estrogen and progesterone. To address whether E2 and P4
regulate the AbdB Hoxa genes Hoxa-9, -11, and -13 in the
uterus, RNase protection assays were performed using
antisense probes for Hoxa-9, -10, -11, -13, and RPL19 in the
same reaction (Fig. 5A) (6 hr post-steroid treatment).
Hoxa-10 and Hoxa-11 exhibit the highest levels of basal
expression, whereas Hoxa-9 expression is approximately
half of a-10. Hoxa-13 was expressed at ;50-fold lower levels
than a-10 and did not appear to be hormonally regulated
(data not shown). Quantitation of the RNase protection
signals by phosphorimager following 6 h of steroid treat-
ment revealed that Hoxa-11 expression is increased by
3.9 6 0.4-fold (n˜ 6 SEM) in response to progesterone, with
2.0 6 0.1-fold activation for Hoxa-10 and 1.5 6 0.07-fold for
Hoxa-9 ( p , 0.02, t test) (Fig. 5B). In contrast, E2 represses
both Hoxa-9 and Hoxa-10 by 0.6 6 0.04-fold, but activates
Hoxa-11 by 1.5 6 0.2-fold. These results were further
corroborated by Northern blot analyses (Fig. 5C) and by in
situ analyses at 6 h, which revealed that the alterations in
expression were stromal (data not shown). By Northern
analysis, P4 again strongly induced both Hoxa-10 and a-11
expression at 6 h, whereas E2 repressed a-10 and activated
a-11. Hoxa-9 expression was only weakly regulated by
hormone treatment and Hoxa-13 expression was not de-
tected. Interestingly, by 24 h Hoxa-10 and a-11 were
strongly upregulated following E2 1 P4 treatment, consis-
tent with the second phase of increased expression observed
at 16 and 24 h in the in situ experiments. Similar to
Hoxa-10, P4-induced upregulation of Hoxa-11 was mark-
edly inhibited by RU486 coadministration (data not
shown). These results indicate that in the adult uterus the
effects of estrogen and progesterone on AbdB Hoxa gene
expression are mainly confined to Hoxa-10 and a-11.
AbdB Hoxa genes are expressed in a nested pattern
along the proximodistal axis of the developing Mu¨llerian
duct. To determine whether the embryonic expression of
AbdB Hoxa genes is also influenced by steroids, we first
analyzed the endogenous expression patterns of these genes
in the developing E16.5 reproductive tract (Fig. 6). At E16.5,
Hoxa-9 expression was detected throughout the uterine
anlage and extended rostrally halfway through the oviduct.
Hoxa-10 expression exhibits a sharp anterior boundary in
the Mu¨llerian duct at the transition between the future
uterus and oviduct. The anterior boundary of Hoxa-11 is the
FIG. 5. AbdB Hoxa cluster regulation of Hoxa-9, a-10, and a-11 by
17b-estradiol (E2) and progesterone (P4). RNase protection assays were
performed on uterine RNAs from ovariectomized hormone-treated
mice 6 h after steroid treatment as described under Materials and
Methods. (A) Multiple probes were used in one RNase protection
reaction to directly compare the hormonal responses of Hoxa-9,
Hoxa-10, and Hoxa-11. Hoxa-13 is expressed at ;50-fold lower levels
in the adult uterus and was not significantly affected in response to
either steroid (data not shown). Uterine RNAs from ovariectomized
mice were used in lanes 1 through 5. Lane 6 is a yeast tRNA negative
control. E15.5 embryonic RNA was analyzed in lanes 7 through 9
with the individual Hoxa RNA probes to show the protected frag-
ments generated with each. (B) Five sets of the above experiment
(performed at 6 h) were analyzed, and band intensities were quanti-
tated by phosphorimager, normalized for loading differences, and
expressed as fold relative to noninjected controls. The graph shows
average values 6 standard error (n˜ 6 SEM). E2 represses both Hoxa-9
and Hoxa-10, but activates Hoxa-11. Hoxa-9, Hoxa-10, and Hoxa-11
exhibit increasing activation in response to P4. The magnitude of the
responses probably appears less than suggested by the in situ analyses
because this assay used total uterine RNA containing both hormon-
ally responsive and nonresponsive components. (C) Northern blot
analyses showing the regulation of Hoxa-10 and Hoxa-11 gene expres-
sion by E2 and P4 consistent with the RNase protection results. Note
that at 24 h Hoxa-10 is strongly induced by E2 1 P4. RPL7 (encoding
ribosomal protein L7) serves as a loading control.
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same as Hoxa-10, but expression starts to diminish just
distal to the boundary of Hoxa-10 (arrow). Finally, expres-
sion of Hoxa-13 is confined to the upper vagina and cervix.
FIG. 6. Hoxa AbdB gene expression in the developing reproduc-
tive tract. E16.5 reproductive tracts were hybridized with Hoxa-9,
Hoxa-10, Hoxa-11, and Hoxa-13 digoxigenin-labeled RNA probes
and detected with an alkaline phosphatase-coupled antidigoxigenin
antibody. The anterior boundaries of expression (arrows) are colin-
ear with cluster position. The arrow in Hoxa-11 in situ indicates
the boundary between strong and much weaker Hoxa-11 expres-
sion in the respective posterior and anterior uterine anlage. The
mesenchymal expression of Hoxa-9, -10, and -11 is visible. Abbre-
viations: o, ovary; md, Mu¨llerian duct; cvx, cervix.
FIG. 7. DES, a synthetic estrogen, represses Hoxa-10 expression in the
developing female reproductive tract. Pregnant female mice or individual
newborn pups were respectively injected daily sc with DES from day 9.5
to 16.5 pc (3 mg/pregnant female/day) (A) or P1–P5 (2 mg/pup/day) (B) and
their reproductive tracts were harvested 6 h after the last injection.
Whole-mount in situ hybridization was performed on both vehicle- and
DES-exposed female reproductive tracts. (A) Approximately 50% reduc-
tion in Hoxa-10 mesenchymal expression in the E16.5 Mu¨llerian duct in
response to prenatal DES exposure. (B) More complete repression at P5 in
response to the higher doses of DES that can be employed in the neonatal
regimen without incurring the fetotoxic effects of high-dose prenatal
DES. The efficacy of DES is apparent from the larger uterine size and
thickened luminal epithelium seen in DES-treated samples compared to
controls. Vibratome sections (100 mm) of the P5 uteri clearly show
dramatic reduction of Hoxa10 expression in the uterine stroma (C, D).
Abbreviations: b, bladder; cvx, cervix; le, luminal epithelium; md, Mu¨l-
lerian duct; o, ovary; s, stroma; u, uterus; v, vagina.
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Sectioning of the whole-mount in situ samples revealed
that expression of Hoxa-9, -10, and -11 is in the stromal
cells (Fig. 7C and data not shown). Thus, the Hoxa AbdB
genes exhibit a nested pattern of expression within the
Mu¨llerian duct which is colinear with their position in the
Hoxa cluster.
The synthetic estrogen DES represses Hoxa10 gene ex-
pression in the developing Mu¨llerian duct. The synthetic
nonsteroidal estrogen DES, when administered perinatally,
induces malformations in the female and male reproductive
tracts (reviewed in Mittendorf, 1995; see Discussion). Some
of these phenotypes bear resemblance to phenotypes ob-
served in Hoxa10 mutant mice. To test whether DES might
act by perturbing Hoxa10 and other AbdB Hoxa gene
expression in the Mu¨llerian duct, we used two dosage
regimens known to induce reproductive tract malforma-
tions in mice (Newbold and McLachlan, 1982). In the
prenatal regimen, DES (100 mg/kg/day) was injected sc from
days 9.5 to 16.5 pc and whole-mount in situ analyses were
performed 6 h after the last injection. Compared to controls,
Hoxa-10 expression was moderately repressed (;50%) in
the Mu¨llerian duct in five of eight DES-exposed embryos
(Fig. 7A); since the nonresponsive embryos were in one
litter, poor absorption of DES may explain this variability.
Under the same condition, partial reduction of Hoxa-13
expression was also observed in the cervix in five of five
DES-exposed embryos (data not shown). Repression of Mu¨l-
lerian duct Hoxa-10 expression was also noted in two of
three embryos when fetotoxic doses of DES (500 mg) were
injected on day 16.5 pc and embryonic urogenital tracts
were assayed 16 h later (data not shown).
Using a second neonatal regimen, it was possible to use
higher doses of DES than in the prenatal regimen and to
avoid the fetotoxic effects of high-dose prenatal DES.
When DES (2 mg/pup/day) was injected sc daily from P1 to
P5 with assay 6 h later, Hoxa-10 was strongly repressed in
all 10 DES-exposed female reproductive tracts (Fig. 7B).
Vibratome sections of the control and DES-exposed uteri
clearly show marked reduction of Hoxa10 expression in
the stroma (Figs. 7C and 7D). Under identical conditions,
Hoxa-9 was strongly and a-11 moderately repressed by
DES (data not shown). The repression of Hoxa10 expres-
sion by DES could also be reproduced in in vitro organ
culture assays after 5 h of DES exposure (Fig. 8). However,
FIG. 8. DES downregulates Hoxa-10 expression in organ culture. Embryonic female reproductive tracts were dissected at E15.5 (A) or
newborn (B, C), incubated in DMEM with or without 1024 M DES for 5 h, and subjected to whole-mount in situ hybridization with either
a Hoxa-10 probe (A, B) or RPL19 probe (C). DES specifically downregulates Hoxa-10 expression in the developing Mu¨llerian duct (A, E15.5,
arrow) or uterus (B, P1, arrow), but has little effect on RPL19 expression in the uterus (C). Abbreviations: b, bladder; md, Mu¨llerian duct;
o, ovary; u, uterus.
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relatively high concentration of DES (1024 M) were
required to effect a complete inhibition of Hoxa10 ex-
pression in both male and female reproductive tracts.
Although the reason for the high in vitro DES dosage
requirement is unclear, the expression of RPL19 was
unaffected in male or female reproductive tracts at this
dose of DES (Fig. 8C). In addition, 1024 M testosterone
and 1024 M dexamethasone were tested and did not affect
Hoxa-10 expression (data not shown). Thus, the repres-
sion by DES in organ culture appears to be a specific
effect. Collectively, these results indicate that DES can
repress the expression of AbdB Hoxa genes in the devel-
oping reproductive ducts under conditions known to
produce female and male reproductive tract malforma-
tions.
DISCUSSION
Steroidal regulation of Hoxa-10 is consistent with its
role during implantation. The finding that Hoxa-10 ex-
pression in the adult uterus is regulated by estrogen and
progesterone is consistent with its demonstrated role in
implantation. Hoxa-10 mutants exhibit a decreased vascu-
lar permeability response and impaired decidualization in
response to an artificial stimulus (Benson et al., 1996). Both
uterine events are among the earliest involved in implan-
tation and are under steroidal control. Increased permeabil-
ity of endometrial capillaries, constituting the earliest re-
sponse of the sensitive endometrium to a deciduogenic
stimulus, is contingent upon nidatory estrogen (reviewed in
Psychoyos, 1973), while uterine decidualization in response
to an artificial stimulus is abolished in PR knockout mice
(Lydon et al., 1995). Thus, Hoxa-10 may participate in
mediating the steroidal regulation of these responses during
early implantation.
Hoxa-10 expression in the endometrial stroma is inhib-
ited by 17b-estradiol and activated by progesterone. A
combination of both steroids results in a restricted pattern
of Hoxa-10 expression limited to the antimesometrial sub-
epithelial stroma. These results are consistent with the
endogenous pattern of Hoxa-10 expression in the stroma
during pregnancy (Satokata et al., 1995). At day 0.5 pc
following the ovulatory pulse of estrogen, Hoxa-10 expres-
sion is undetectable in the stroma. Subsequently, with the
formation of the corpora lutea on day 2.5 pc, progesterone
levels rise and are correlated with increasing Hoxa-10
expression in the stroma. On day 3.5, a second pulse of
estrogen occurs producing a combined estrogen and proges-
terone environment. We observed that E2 1 P4 coadminis-
tration produces a narrowly restricted antimesometrial
phase of Hoxa-10 stromal expression within 4 h. Interest-
ingly, in 3 of 14 nonsynchronized day 3.5 pc uteri taken
from nonovariectomized females, we observed either local-
ized or stronger Hoxa-10 expression at the antimesometrial
pole, the site of blastocyst implantation in the rodent
uterus (data not shown). Therefore, the antimesometrial
bias in Hoxa-10 stromal expression induced by E2 1 P4
could represent a transient phase of endogenous Hoxa-10
expression during implantation.
While the stromal component of Hoxa-10 expression is
under the control of ovarian steroids, the epithelial expres-
sion seen on day 0.5 of pregnancy is not observed in the
estradiol-treated uteri. Other genes such as c-myc which are
normally coexpressed with Hoxa-10 in the day 0.5 pc
proliferative epithelium were detected. It is possible that
either Hoxa-10 is not induced by the doses of estradiol used
here or alternatively the epithelial expression of Hoxa-10 is
estradiol independent. Epithelial expression of COX-2 has
been shown to be inducible by LPS, suggesting upregulation
as part of a postcopulatory inflammatory response
(Chakraborty et al., 1995). This phenomenon could explain
how a steroid-independent change in expression could be
specifically induced on day 0.5 pc.
The steroidal modulation of Hoxa-10 expression in the
stroma was very rapid, with both positive and negative
regulation apparent within 4 h. The kinetics of the Hoxa-10
response suggested that it may be a direct target of estrogen
and progesterone receptors. ER and PR are ligand-inducible
transcription factors of the nuclear hormone superfamily
and are present in all compartments of the uterus (Weisz
and Bresciani, 1993; reviewed in Truss and Beato, 1993).
Addition of RU486 at least partly blocks the P4 induction of
Hoxa-10 expression, demonstrating that the PR is involved
in this regulation. The directness of the Hoxa-10 response
was tested by inhibiting the synthesis of new proteins with
cycloheximide during the period of steroid exposure. The
expression of c-myc was used as a control for this study.
Consistent with the observations in MCF7 cells (Truss and
Beato, 1993), the E2 induction of c-myc in the epithelium
was prevented by cycloheximide. The slight increase in
stromal c-myc in response to progesterone is also consistent
with the requirement for new protein synthesis in the
steroidal control of c-myc mRNA turnover. In contrast to
c-myc, neither the inhibition of Hoxa-10 by E2 nor its
activation by progesterone was affected by cycloheximide.
These results suggest that Hoxa-10 may be a direct target of
estrogen and progesterone receptors.
While the resistance of Hoxa-10 regulation to cyclohexi-
mide is most easily viewed as supporting a direct regula-
tion, these experiments do not rule out an indirect effect. It
is possible that there is sufficient residual protein synthesis
to modulate Hoxa-10 expression. Alternatively, ER and PR
could act in an indirect manner. For example, RARs and
RXRs can repress transcription via protein–protein interac-
tions with AP-1 proteins (reviewed in Chambon, 1996, and
references cited therein). Thus, while we favor the hypoth-
esis that Hoxa-10 is a direct target of estrogen and proges-
terone receptors, dissection of Hoxa-10 regulatory elements
will be necessary to establish this.
Steroidal regulation of AbdB Hoxa genes. The response
of Hox genes to nuclear hormone receptors has been studied
extensively with regard to retinoid receptors (Conlon, 1995;
Means and Gudas, 1995; Marshall et al., 1996). Sensitivity
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to RA is colinear with position along the Hox cluster, and
the response of Hox genes to different thresholds of RA has
been proposed to be a mechanism for establishing their
colinear pattern of expression along the AP axis. The
regulation of Hox gene expression by retinoic acid is a
cluster-related property in which there is a decrease in
sensitivity to retinoic acid from 39 to 59 Hox genes. In fact,
consistent with the L1 3 T14 anterior homeotic transfor-
mation observed in Hoxa-10 mutants (Satokata et al., 1995),
administration of RA at day 8 pc represses embryonic
Hoxa-10 expression in prevertebrae 21 and produces em-
bryos with a similar transformation (Kessell, 1992). In
addition, in EC cells, high doses of RA repress AbdB Hoxd
gene expression (Simeone et al., 1991). Thus, RA appears to
be one potential regulator of AbdB Hox gene expression.
Our data indicate that ovarian steroids can regulate AbdB
Hoxa gene expression as well.
In the adult uterus, progesterone activates Hoxa-9, -10,
and -11 expression in a manner that parallels their colin-
earity within the AbdB region of the Hoxa cluster. In
contrast, estradiol represses Hoxa-9 and -10 but activates
Hoxa-11. The significance of the differential regulation of
a-11 by estradiol is unclear, but could reflect usage of
different response elements within the respective genes.
Although both a-10 and a-11 mutant females are infertile
(Benson et al., 1996; Gendron et al., 1997), their differential
regulation by estradiol suggests different functions for a-10
and a-11 during implantation. Functional dissections of the
ER have not revealed any repressor domains which could
mediate E2 inhibition; however, precedent exists for the
interaction of steroid hormones with both positive and
negative regulators of transcription (Truss and Beato, 1993).
Interestingly, Hoxa-13 does not appear to be significantly
expressed in the adult uterus; however, its human homolog
is expressed in adult cervix and upper vagina (Taylor et al.,
1997), and a-13 could be sensitive to hormonal regulation in
these tissues.
Recent evidence also supports a role for other nuclear
hormone receptors in the regulation of Hox genes. The
expression of Hoxc-6 in the murine mammary gland was
observed to be increased following ovariectomy (Friedmann
et al., 1994), demonstrating responsiveness to secreted
ovarian factors, presumably steroids. In addition, the ex-
pression of Hoxa-1 was found to be induced at 24 h
following culture of MCF7 cells with a synthetic progestin
in an RT-PCR analysis (Chariot and Castronovo, 1996).
Finally, during vitamin D3 induced differentiation of the
myelomonocytic cell line U937, expression of HoxA-10 was
upregulated within 4 h of exposure (Rots et al., 1998).
The binding sites for the estrogen receptor and progester-
one receptors have been identified as inverted repeats with
trinucleotide spacers (IR3) of GGTCA and GGTACA half-
sites, respectively (Truss and Beato, 1993). A search of the
available Hoxa-10 and Hoxa-11 genomic sequences reveals
several consensus binding sites for the estrogen and proges-
terone receptors. Moreover, a putative PRE and three im-
perfect EREs have been identified in the intergenic region of
Hoxc-8 and Hoxc-9 (Awgulewitsch et al., 1990), indicating
that such elements are present in the regulatory regions of
other 59 Hox genes. In addition, the ER may bind to direct
repeats of its half-site separated by 10–200 bp with an
activity of approximately 30% of the canonical IR3 site
(Kato et al., 1995). A naturally occurring example of this
unconventional binding site is present in the chick ovalbu-
min promoter. A unique feature of widely spaced EREs is
that they can also bind RARs and VitDRs. Given the
response of Hox genes to all three of these nuclear family
hormone receptors, such a promiscuous site could be rel-
evant here.
Hoxa10 gene expression is repressed by the synthetic
estrogen DES during reproductive tract morphogenesis.
Extensive studies document that reproductive tract malfor-
mations are induced in both humans (Haney et al., 1979;
Kaufman et al., 1980;DeCherney et al., 1981) and mice
(McLachlan et al., 1980; Newbold and McLachlan, 1982;
Newbold et al., 1983a,b; Haney et al., 1986) following
perinatal exposure to the synthetic nonsteroidal estrogen
DES (reviewed in Mittendorf, 1995). One malformation,
DES-induced vaginal adenosis, is observed in daughters of
women exposed to DES during pregnancy and predisposes
to later development of a rare clear cell form of vaginal
adenocarcinoma (Herbst et al., 1971; Greenwald et al.,
1971). DES-induced malformations have been suggested to
derive from abnormal morphogenesis of the Mu¨llerian and
Wolffian ducts. DES has been proposed to exert its effects
upon the developing reproductive tract by its estrogenic
activity. Here we show that DES potently represses Hoxa10
and other AbdB Hoxa gene expression in the Mu¨llerian
duct. The phenotypes associated with loss of AbdB Hoxa
gene function establish that these genes are not merely
markers but actual regional determinants of Mu¨llerian duct
identity. Hence, the repression of these genes by DES
provides an attractive potential mechanism for the terato-
genic effects of DES upon the developing female reproduc-
tive tract.
Hoxa-10 knockout mice exhibit an anterior homeotic
transformation of the proximal 25% of the uterus to ovi-
duct, abnormalities of the uterotubal junction, paraovarian
cysts, and stratification of the distal uterine epithelium
(Benson et al., 1996). Hoxa-11 knockout mice exhibit a thin
abnormally shaped uterus that lacks endometrial glands
(Gendron et al., 1997), Hoxa-13 knockout embryos exhibit
agenesis of the distal Mu¨llerian duct (Warot et al., 1997),
and naturally occurring Hd (hypodactyly) mice mutant in
Hoxa-13 exhibit both histologic and morphologic abnor-
malities at the uterocervical junction and vesicovaginal
fistula (Mortlock et al., 1996; J. Innis, personal communi-
cation). These phenotypes are concordant with the nested
pattern of AbdB Hoxa gene expression along the Mu¨llerian
duct and also with the principle that Hox gene loss of
function mutations affect segments at the anterior bound-
aries of expression. Therefore, a phenotypic colinearity
exists and the Hoxa cluster AbdB genes define a proximo-
distal axis in the reproductive tract analogous to that
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previously proposed for the paralogous AbdB genes of the
Hoxd cluster (Dolle´ et al., 1991).
Although not identical, the phenotypes induced by
DES are similar to those in AbdB Hoxa mutant mice.
DES-induced oviductal malformations include loss of the
boundary between the oviduct and uterus associated with
a loss of functional integrity of the uterotubal junction,
paraovarian cysts, and developmental arrest of the ovi-
duct (DAO) (Newbold et al., 1983a,b; DeCherney et al.,
1981; Haney et al., 1979). The first two features are
present in Hoxa-10 mutant mice (Benson et al., 1996).
Other features of the DES phenotype include the abnor-
mal presence of glands in the vaginal fornix (vaginal
adenosis), abnormal urethral openings in the vagina (per-
sistent urogenital sinus), and failure of distal Mu¨llerian
ducts to form a common cervical canal (Newbold and
McLachlan, 1982). These phenotypes correlate with
those noted above for Hd mice null for Hoxa-13 and for
Hoxa-131/2, Hoxd-132/2 genetic compounds (Warot et
al., 1997). Finally, male rodents exposed to DES or other
estrogens perinatally exhibit cryptorchidism, hypospa-
dias, hypoplastic or absent seminal vesicles, vas deferens,
epididymis, and dorsal and ventral prostate, typically
with a reduced number of prostatic diverticula, and
abnormalities of the coagulating gland epithelium
(McLachlan et al., 1975; Vorherr et al., 1979; Greene et
al., 1940). Similar cryptorchidism and seminal vesicle,
vas, epididymal, prostatic, and other accessory sex organ
malformations are observed in Hoxa-10, a-11, and d-13
mutant males (Satokata et al., 1995; Rijli et al., 1995;
Benson et al., 1996; Hsieh-Li et al., 1995; Podlasek et al.,
1997; and manuscript in preparation), while males af-
fected by an HFG syndrome mutation in HOXA13 ex-
hibit hypospadias of variable severity (Mortlock and
Innis, 1997). Thus, the phenotypes observed following
DES exposure can be reconciled with the predicted con-
sequences of DES-induced alterations in AbdB Hoxa gene
expression.
DES treatment has also been associated with morpho-
logic findings which are not related to phenotypes in Hoxa
mutant mice. Therefore, it seems likely that some terato-
genic effects of DES are not mediated by perturbation of
AbdB Hox codes. For example, neonatal DES exposure leads
to the constitutive expression of lactoferrin and EGF in the
prostate and of c-fos in the uterus and vagina (Nelson et al.,
1994; Salo et al., 1997). However, our results suggest that
the DES phenotype could partly represent the result of
transient, incomplete repression of multiple AbdB Hox
genes. In addition, the data raise the possibility that the
establishment of an AbdB Hoxa code during reproductive
patterning is regulated by endogenous steroids, retinoids, or
their metabolites.
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